Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nanus

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Critical Reviews in Oncology/Hematology|August 22, 2025
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitorsPier Vitale Nuzzo, Silvia Rodrigues, Caroline Fidalgo Ribeiro, et al.
Cancer Causes & Control : CCC|March 11, 2022
Cancer and cardiovascular-related perceived risk in a diverse cancer center catchment areaLaura C Pinheiro, Orysya Soroka, Dominic Razon, et al.
Translational Oncology|December 23, 2019
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell CarcinomaJohannes C van der Mijn, Leiping Fu, Francesca Khani, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 21, 2025
ATF4 in proximal tubules modulates kidney function and modifies the metabolomeYuling Chi, Eduardo Mere Del Aguila, Tuo Zhang, et al.
The Prostate|July 10, 2023
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapyJudith Stangl-Kremser, Michael Sun, Benedict Ho, et al.
Scientific Reports|May 22, 2023
Novel genetically engineered mouse models for clear cell renal cell carcinomaJohannes C van der Mijn, Kristian B Laursen, Leiping Fu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinomaStephen A Boorjian, Matthew I Milowsky, Jodi Kaplan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 7, 2009
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterationsDavide Tampellini, Nawreen Rahman, Eduardo F Gallo, et al.
JAMA Network Open|April 14, 2026
Barriers to Health Care and Cancer ScreeningAaron A Gurayah, Anjile An, Manish Kuchakulla, et al.
Elife|July 18, 2022
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancerSeaho Kim, CheukMan C Au, Mohd Azrin Bin Jamalruddin, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Critical Reviews in Oncology/Hematology|August 22, 2025
Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitorsPier Vitale Nuzzo, Silvia Rodrigues, Caroline Fidalgo Ribeiro, et al.
Cancer Causes & Control : CCC|March 11, 2022
Cancer and cardiovascular-related perceived risk in a diverse cancer center catchment areaLaura C Pinheiro, Orysya Soroka, Dominic Razon, et al.
Translational Oncology|December 23, 2019
Combined Metabolomics and Genome-Wide Transcriptomics Analyses Show Multiple HIF1α-Induced Changes in Lipid Metabolism in Early Stage Clear Cell Renal Cell CarcinomaJohannes C van der Mijn, Leiping Fu, Francesca Khani, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 21, 2025
ATF4 in proximal tubules modulates kidney function and modifies the metabolomeYuling Chi, Eduardo Mere Del Aguila, Tuo Zhang, et al.
The Prostate|July 10, 2023
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapyJudith Stangl-Kremser, Michael Sun, Benedict Ho, et al.
Scientific Reports|May 22, 2023
Novel genetically engineered mouse models for clear cell renal cell carcinomaJohannes C van der Mijn, Kristian B Laursen, Leiping Fu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 2, 2007
Phase 1/2 clinical trial of interferon alpha2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinomaStephen A Boorjian, Matthew I Milowsky, Jodi Kaplan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 7, 2009
Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterationsDavide Tampellini, Nawreen Rahman, Eduardo F Gallo, et al.
JAMA Network Open|April 14, 2026
Barriers to Health Care and Cancer ScreeningAaron A Gurayah, Anjile An, Manish Kuchakulla, et al.
Elife|July 18, 2022
AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancerSeaho Kim, CheukMan C Au, Mohd Azrin Bin Jamalruddin, et al.
Pageof 17